IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-40923-5.html
   My bibliography  Save this article

Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling

Author

Listed:
  • Daniel C. Souza

    (Massachusetts General Hospital
    Harvard Medical School
    Massachusetts General Hospital)

  • Nicolas Hebert

    (French Blood Establishment (EFS)
    IMRB, Laboratory of excellence LABEX
    Sickle Cell Referral Center—UMGGR)

  • Erica B. Esrick

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Harvard Medical School
    Harvard Medical School)

  • M. Felicia Ciuculescu

    (Harvard Medical School)

  • Natasha M. Archer

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Harvard Medical School
    Harvard Medical School)

  • Myriam Armant

    (Harvard Medical School)

  • Étienne Audureau

    (Paris-East Créteil University
    Henri Mondor University Hospitals, APHP)

  • Christian Brendel

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Harvard Medical School
    Harvard Medical School)

  • Giuseppe Caprio

    (Massachusetts General Hospital
    Harvard Medical School
    Boston Children’s Hospital
    University of Strathclyde)

  • Frédéric Galactéros

    (IMRB, Laboratory of excellence LABEX
    Sickle Cell Referral Center—UMGGR)

  • Donghui Liu

    (Harvard Medical School)

  • Amanda McCabe

    (Harvard Medical School)

  • Emily Morris

    (Harvard Medical School)

  • Ethan Schonbrun

    (Massachusetts General Hospital)

  • Dillon Williams

    (University of Minnesota)

  • David K. Wood

    (University of Minnesota)

  • David A. Williams

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Harvard Medical School
    Harvard Medical School)

  • Pablo Bartolucci

    (IMRB, Laboratory of excellence LABEX
    Sickle Cell Referral Center—UMGGR)

  • John M. Higgins

    (Massachusetts General Hospital
    Harvard Medical School
    Massachusetts General Hospital)

Abstract

We previously reported initial clinical results of post-transcriptional gene silencing of BCL11A expression (NCT 03282656) reversing the fetal to adult hemoglobin switch. A goal of this approach is to increase fetal hemoglobin (HbF) expression while coordinately reducing sickle hemoglobin (HbS) expression. The resulting combinatorial effect should prove effective in inhibiting HbS polymerization at lower physiologic oxygen values thereby mitigating disease complications. Here we report results of exploratory single-cell analysis of patients in which BCL11A is targeted molecularly and compare results with cells of patients treated with hydroxyurea (HU), the current standard of care. We use single-cell assays to assess HbF, HbS, oxygen saturation, and hemoglobin polymer content in RBCs for nine gene therapy trial subjects (BCLshmiR, median HbF% = 27.9) and compare them to 10 HU-treated subjects demonstrating high and comparable levels of HbF (HU High Responders, median HbF% = 27.0). All BCL11A patients achieved the primary endpoint for NCT 03282656, which was defined by an absolute neutrophil count greater than or equal to 0.5 × 109 cells/L for three consecutive days, achieved within 7 weeks following infusion. Flow cytometric assessment of single-RBC HbF and HbS shows fewer RBCs with high HbS% that would be most susceptible to sickling in BCLshmiR vs. HU High Responders: median 42% of RBCs with HbS%>70% in BCLshmiR vs. 61% in HU High Responders (p = 0.004). BCLshmiR subjects also demonstrate more RBCs resistant to HbS polymerization at lower physiologic oxygen tension: median 32% vs. 25% in HU High Responders (p = 0.006). Gene therapy-induced BCL11A down-regulation reverses the fetal-to-adult hemoglobin switch and induces RBCs with higher HbF%, lower HbS%, and greater resistance to deoxygenation-induced polymerization in clinical trial subjects compared with a cohort of highly responsive hydroxyurea-treated subjects.

Suggested Citation

  • Daniel C. Souza & Nicolas Hebert & Erica B. Esrick & M. Felicia Ciuculescu & Natasha M. Archer & Myriam Armant & Étienne Audureau & Christian Brendel & Giuseppe Caprio & Frédéric Galactéros & Donghui , 2023. "Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling," Nature Communications, Nature, vol. 14(1), pages 1-10, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-40923-5
    DOI: 10.1038/s41467-023-40923-5
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-40923-5
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-40923-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Joel A. Spencer & Francesca Ferraro & Emmanuel Roussakis & Alyssa Klein & Juwell Wu & Judith M. Runnels & Walid Zaher & Luke J. Mortensen & Clemens Alt & Raphaël Turcotte & Rushdia Yusuf & Daniel Côté, 2014. "Direct measurement of local oxygen concentration in the bone marrow of live animals," Nature, Nature, vol. 508(7495), pages 269-273, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Alexandra N. Rindone & Xiaonan Liu & Stephanie Farhat & Alexander Perdomo-Pantoja & Timothy F. Witham & Daniel L. Coutu & Mei Wan & Warren L. Grayson, 2021. "Quantitative 3D imaging of the cranial microvascular environment at single-cell resolution," Nature Communications, Nature, vol. 12(1), pages 1-13, December.
    2. Jianping Wang & Bin Zhao & Jingmin Che & Peng Shang, 2023. "Hypoxia Pathway in Osteoporosis: Laboratory Data for Clinical Prospects," IJERPH, MDPI, vol. 20(4), pages 1-22, February.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-40923-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.